BALTIMORE, Md.--DNA Bactofection, a novel technology for introducing genes into cells using live, attenuated invasive bacterial vectors, has been licensed to Microscience Ltd. by the University System ...

LONDON - Microscience Ltd. is being acquired by U.S. company Emergent BioSolutions Inc. in an all-paper deal that values the vaccine specialist at £40 million (US$73.1 million), roughly £5 million ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

LONDON - Microscience Ltd. is forming a 50-50 joint venture company with the Hamburg, Germany, drug discovery services company Evotec OAI to develop small-molecule antimicrobial drugs based on targets ...

The University of Maryland Biotechnology Institute announced Friday that it has licensed to Microscience Ltd. a technology delivers DNA into cells. The licensing agreement allows United Kingdom-based ...

FLOTATION of a Wokingham-based biotechnology company will net £10m for its management and founders, including five London doctors. Microscience intends to float on Aim next month, raising £40m of new ...

Microscience, the vaccines developer, pulled its £140m stock market flotation yesterday, blaming poor market demand for its shares. It announced plans to float on the Alternative Investment Market in ...

The event is organized by the UK-based Royal Microscopical Society (RMS), and will open with a plenary lecture from Sir David King, who was science and technology advisor to the UK government from ...

Microscience, London, raised $36.4 million in third-round funding. The investment was led by Advent Venture Partners, J.P. Morgan Partners, Apax Partners Funds, and Merlin Biosciences. The company ...